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Abstract: 
Gram-negative bacilli, Enterobacteriaceae and Non-fermentors with resistance to carbapenems and metallo beta-lactams are the major 
cause of concern in clinical problems in current human healthcare. The most highly emerging dreadful Metallo Beta-lactamses is 
New Delhi metallo-beta-lactamase (blaNDM-1) which confers resistance to carbapenems; susceptible only to colistin and, less 
consistently to tigecycline, leading to no therapeutic options. In the present study, we demonstrate the effects of cephalosporins 
and carbepenems on biofilm producing A. baumanii clinical isolate and also to infer the probable inhibitory binding mode through 
molecular docking studies. The result of MIC on Biofilm producing A. baumanii and the docking analysis results were found to be 
concordant. Moreover, we also found cephalosporins and carbepenem groups to interact with 162-166 region of blaNDM-1, which 
is unique for NDM-1 and also documented to be a potential drug targeting region. 
 
 
 
Background:  
Antibiotic-resistant Gram-negative bacilli belonging to 
Enterobacteriaceae and Non-fermentors are the major cause of 
concern in clinical problems in current human healthcare [1, 2] 
Beta-lactams have been the mainstay of treatment for serious 
infections in humans [3]. Among Gram-negative bacteria, the 
most common beta-lactam resistance mechanism involves beta-
lactamase mediated hydrolysis which results in inactivation of 
antibiotics which are used in the treatment of infection caused 
by these organisms and are being reported in increasing 
frequencies [4]. One of the last lines of treatment against high 
level drug resistant infections is the carbapenems and are 
metallo-beta-lactams (MBL) class of antibiotics, which was 
developed to resist the beta-lactamase mediated resistance 
posed by infection causing microbes [5, 6]. Recent studies has 
proved the inactivation of these carbapenams (meropenem, 
imipenem, doripenem, ertapenem) by a number of metallo-
beta-lactamases which poses extended spectrum activity against 
all beta-lactam antibiotics, including carbapenems [5-7]. One 
such highly emerging dreadful MBL’s is New Delhi metallo-
beta-lactamase (blaNDM-1).  This blaNDM-1 is a novel MBL’s 
conferring resistance to almost all beta-lactam antibiotics, 
including carbapenem [8-11]. Many reports are emerging on the 
existence and prevalence of blaNDM-1 throughout the world [3, 
4, 7, & 12]. Microorganisms carrying blaNDM-1gene are E. coli, 
K. pneumoniae, K. oxytoca, Enterobacter cloacae, Proteus spp., 
Citrobacter freundii, Morganella morganii, Providencia  spp. 
Pseudomonas aeroginosa [2, 3, 8] and also in Acinetobacter BIOINFORMATION  open access 
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baumannii [12, 13]. Presence of blaNDM-1 gene was also 
detected among bacteria isolated from seepage samples and 
public tap waters in New Delhi, India [14].  Many reports have 
revealed the spread of blaNDM-1 through renal or bone marrow 
transplantation, dialysis, cerebral infarction, chronic obstructive 
pulmonary disease, pregnancy, burns, road traffic accidents, 
and cosmetic surgery [3] Hence, the microorganism carrying the 
blaNDM-1 gene will be extensively resistant to antibiotics and 
susceptible only to colistin and, less consistently, tigecycline, 
leading to scarcity of antibiotics for treatment [8, 11]. 
Acinetobacter baumannii is a common nosocomial pathogen 
reported worldwide [15]. Infections caused by A. baumannii are 
associated with adverse clinical outcomes, including high rates 
of morbidity and mortality, prolonged hospital stay, and 
substantial health care expenses. Many reports on emergence of 
blaNDM-1 among A. baumannii have been reported [13, 16].  In 
our previous study, we have isolated blaNDM -1 carrying  A. 
baumannii  with high drug resistance  was isolated from a 
multiorgan donor. [17]. Though reports on the three 
dimensional structures of blaNDM-1, active site regions, 
molecular docking and ligands complex molecular dynamic 
simulation studies in different microbial pathogenic organisms 
synthesis different protein length of blaNDM-1 exist, in this 
study we aimed to correlate the microbiological investigations 
carried out to screen its level of drug resistance with that of in 
silico studies of drug interactions using bioinformatics tools. 
 
Methodology: 
A. baumanii, isolated from a conjunctival swab collected from a 
23 years old multi organ donor, died in a road traffic accident 
was utilized for this study, after validation through 
documented bacteriological methods [18]. Further, the isolate 
was screened for the presence of blaNDM-1 at clinical 
microbiology laboratory of L & T Microbiology Research Centre 
from Sankara Nethralaya, Chennai. The bacterium was found to 
harbor the blaNDM-1 by PCR based DNA technique and was 
further sequenced for confirmation. The sequence obtained was 
submitted to Genbank [Accession no: JF836807]. 
 
Biofilm production detection: 
Detection of Biofilm production by Tissue culture plate method 
Biofilm production of A. baumanii isolate was carried out 
aerobically in 96 well round bottom tissue culture plate as 
described earlier [19, 20] with slight modifications.  The 
adherent biofilm producing cells was released by adding 160 ml 
33% acetic acid (SRL, India). The sterile uninoculated brain 
heart infusion broth media served as medium control to check 
sterility. Carbapenem susceptible  K. pneumoniae ATCC BAA-
1706 and carbapenem resistant K. pneumoniae ATCC BAA-1705 
served as the inoculum control. Optical density (OD) of stained 
adherent bacteria was determined with a micro ELISA (ELX808, 
Biotek, India) auto reader at a wavelength of 520 nm. These OD 
values were considered as an index of bacteria adhering to 
surface and forming biofilms.  The experiment was performed 
in triplicate and the average was derived. To compensate the 
background absorbance, OD readings from sterile medium, 
fixative, dye were averaged and subtracted from all the test 
values. The mean OD value obtained from media control well 
was deducted from all the test OD values.  
 
Interpretation of bacterial adherence 
The bacterial adherence was interpreted based on OD values as 
obtained for A. baumanii isolate [19]. The mean OD values 
derived is shown below in Table 1 (see supplementary 
material) 
 
Detection of viability of biofilm producing bacteria after 
antibacterial treatment:  
Production of biofilm 
The bacterial isolate was allowed to produce biofilm by 
inoculating 200µl of 1:10 diluted A. baumanii isolate onto three 
96 well round bottom tissue culture plate and incubated 
aerobically at 370C for 24 hours as described earlier [19, 20].  
After 24 hr of growth, the biofilm production was checked out 
in one of the plate by procedure described above.   
 
Antibacterial treatment of Biofilm 
After confirming the production of biofilm, the remaining 
plates were subjected for antimicrobial susceptibility testing by 
microbroth dilution method. The medium was first removed by 
aspiration from the wells and subjected for antibiotic treatment 
with ceftriaxone (Alkem, India), cefepime (Zuventus, India), 
cefoperazone (Pfizer, India), imepenum (Ranbaxy, India) and 
meropenum (Blue cross, India). The bacteria were then treated 
with various concentrations of the antibiotics ranging from 
1280mg/L – 10mg/L and incubated for 24 hours at 37°C 
(carried out in duplicates). After overnight incubation, the 
medium containing the antimicrobial agent was gently 
aspirated out.  
 
Assessment of cell morphology by pseudo- confocal microscope 
The reduction in the amount of bacterial cell count was 
observed under Axio Observer fluorescent microscope (Carl 
Zeiss, Berlin, and Germany). The images were processed using 
Axio Vision 4.7 software (Carl Zeiss, Bangalore, India).  
 
MTT assay 
Following this, the viability of the bacteria in each of the 
antibiotic concentration was tested by MTT (3-[4, 5-
dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide, 
Invitrogen, India) assay according to the method described by 
Kairo  et al (1999) [21]. Briefly, after 24 h lasting antibiotic 
treatment, the wells of micro plate were aspirated out and filled 
with 150 µl of PBS per well, then 50µl of MTT solution (0.3% in 
PBS) was added. Plates were incubated for 2 h at 37°C. At the 
end of incubation period, MTT was replaced with 150 µl of 
DMSO (Merck, India). To enable complete dissolving of formed 
purple formazan crystals, the plates were incubated for 15 
minutes at room temperature followed by a gentle agitation for 
5 min. The optical density of the wells was calculated through 
micro ELISA auto reader at wavelength of 550 nm. Cell viability 
(or cell survival) was calculated as: (Test OD/Control OD) ×100. 
The 50% inhibitory concentration (IC50) of the five drugs 
(ceftriaxone, cefepime, cefoperazone, imepenum and 
meropenum) was computed using polynomial regression 
analysis using Microsoft Excel. 
 
Conjugation experiment 
To obtain the transconjugant, 0.2 ml of an exponentially grown 
culture of the test strain A. baumanii (donor cells) was mixed 
with 1.8 ml of an overnight culture of E. coli XL-1 Blue (recipient 
cells) in LB broth (Hi media, India). Mixtures were incubated 
without shaking at 37°C for 18 h. Transconjugants were selected 
by their ability to resist streptomycin 65 μg/ml (Oxoid), BIOINFORMATION  open access 
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tetracycline 100 μg/ml (Merck, India) and cefotaxime 2 µg/ml 
(Himedia, India) incorporated in LB agar [22, 23]. The 
transconjugants were preceded further for the antibiotic 
susceptibility testing with the same antibiotic which was used 
for testing parental isolates. 
 
Sequence Retrieval 
The Protein sequence for blaNDM-1 in Acinetobacter baumannii 
(UniProtKB accession number: F8UNN7) was retrieved from 
UniProtKB [24]. BLASTP search was carried out for this protein 
against the PDB [25] to detect the most suitable template for 
modeling, wherein, E. coli blaNDM-1 crystal structure (PDB id: 
3S0Z) was found to have 100% identity. So, the PDB structure 
3S0Z was retrieved from the Protein Data Bank and the same 
was used for structural studies. However, the crystal structure 
had a missing loop region [167-170] which was modeled and 
validated by different structural assessment studies [26].  
 
Structure validation 
The crystal Structure (3SOZ) was fixed for missing loop, and 
was examined by using Q-MEAN SERVER, which estimates 
quality of a model, whereby, it gives two different scores: 
Global score, which includes Q-Mean Score which is a global 
score of the whole model reflecting predicted model reliability 
ranging from 0 to 1, Z-Score which is calculated by relating Q-
Mean score to scores of a non-redundant set of high-resolution 
x-rays structures of similar size. Local Score includes Residue 
Error which was estimated per residue [27]. Ramachandran plot 
validation was also performed using Structure Analysis & 
Verification (SAVES) server [28].  
 
Molecular Dynamics (MD) Studies of blaNDM-1 protein 
MD Simulation was performed for the modeled protein on 
OPEN DISCOVERY Linux Platform with pre-installed 
GROMACS software [29] to analyze the stability of the protein. 
GROMOS96 43al [30] force field was used. Periodic boundary 
conditions were applied with 0.9nm of cubic box. The protein 
was solvated with SPC water model which added 11619 SOL 
molecules to the system. System was neutralized by replacing 
water molecules with 10 NA+ counter ions. Steepest Descent 
algorithm was used for energy minimization which converged 
in 283 steps. Equilibration of the NVT and NPT ensembles was 
conducted separately each with 100ps and with 2 fs of 
integration time steps.  The final production run was performed 
for 5ns. Finally, the decoy with least potential energy was 
chosen for further studies.  
 
Prediction of Active site 
The binding pocket for the target protein was predicted using 
computed atlas of surface topography of proteins (CASTP) [31]. 
Further, all the binding pockets residues were compared with 
the documented active site residues the protein [32]. Binding 
Pocket from CASTP was selected which covers all the active site 
residues of the protein. Finally, this binding pocket was used 
for further docking studies. 
 
Retrieval of Ligands 
The structural coordinates of the ligands were retrieved from 
Ligand Depot, Pubchem and Drug Bank based on availability. 
The ligands are Ceftriaxone (Pub Chem: CID 5479530); 
Cefepime (Pub Chem: CID 5479537); and Cefoperazone (Pub 
Chem: CID 44185) Carbapenems which includes Imipenum 
(Drug Bank: DB01598) and Meropenum (PDB ID: 3q82); 
Optimisation of all the ligands were done in ProDrg server [33].  
 
Molecular Docking Studies 
Auto Dock 4.0 [34] was used for carrying out docking studies of 
blaNDM-1 protein with all the five different types of ligands. 
Semi-flexible docking was done in which protein was kept as 
rigid and the ligands as flexible [35]. For all the ligands, the 
possible torsion angles were set to rotate freely. In the 
preparation of protein, polar hydrogens were added and 
kollman united partial charges were also assigned. Gasteiger 
charges were also assigned to the ligands. Auto Dock 4.0 was 
compiled and run under Linux operating system. Auto Dock 
requires pre assigned grid maps, and grid must surround the 
region of interest in the protein. In this study, binding site 
residues were generated by CASTp server, which includes all 
the active site residues were used for setting the grid. The grid 
box size was set at 100, 100 and 100 Å (x, y and z) and grid 
center 3.0, 3.0, 3.0 for x, y and z- coordinates for all ligand 
molecules. The spacing between grid point was 0.375 Å for 
active site in such a way to surround the entire given binding 
site residues. The Lamarckian Genetic Algorithm parameter 
was used for the best docking conformers. The following 
parameters were followed for all the compounds. A maximum 
of 10 conformers were considered for each compound, the 
population size was 150, maximum number of evaluation was 
set to 2,500,000, maximum number of generations was 27,000, 
rate of gene mutation was 0.02, rate of crossover was 0.80, GA 
crossover mode two pt (two point), mean of Cauchy 
distribution for gene mutation was 0.0, variance of Cauchy 
distribution for gene mutation was 10.0, and number of 
generation for picking worst individual was set to 10. 
 
 
Figure 1: Tissue culture plate showing Biofilm production by A. 
baumanii isolate. 
 
Results: 
Results of in vitro biofilm production 
The isolate from the donor corneal rim specimen produced high 
level of biofilm with an OD of 0.361 at an absorbance of 520nm. BIOINFORMATION  open access 
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Biofilm produced by the A. baumannii isolate is shown in 
(Figure 1). 
 
Results of viability of biofilm producing bacteria after 
antibacterial treatment  
The viability of biofilm producing A. baumanii isolate reduced 
on exposure to antibiotics and was inferred by reduction in the 
bacterial cell count after antibiotic treatment.  (Observed 
through Axio Observer fluorescent microscope (Carl Zeiss, 
Berlin, and Germany). The degree of biofilm formation and 
percent of viability of bacterial cells after antibiotic treatment 
were analyzed by MTT staining. Higher degree of resistance 
was observed for all 5 drugs (ceftriaxone, cefepime, 
cefoperazone, imepenum and meropenum) after 24 hours of 
antibiotic treatment. The IC50 of ceftriaxone, cefepime, 
cefoperazone, imepenum and meropenum to be 80 mg/L, 80 
mg/L, 80 mg/L, 80 mg/L, and 80 mg/L, respectively. Effect of 
imepenum on A. baumannii at various concentrations is shown 
in (Figure 2). 
 
 
Figure 2: Morphology of A. baumanii cells at various 
concentrations of imepenum are seen under Axio Observer 
fluorescent microscope (A) Control, B) At an imepenum 
concentration of 40 mg/L, C) At an imepenum concentration of 
80 mg/L and D) At an imepenum concentration of 160 mg/L). 
Sensitivity of A. baumanii cells to increasing concentrations of 
antibiotics 
 
 
Figure 3: Line graph representing percentage of viability of A. 
baumanii cells to increasing concentrations of antibiotics. 
(Figure 3) presents the percentage viability of A. baumannii at 
various concentrations of antibiotics ie. ceftriaxone, cefepime, 
cefoperazone, imepenum and meropenum at increasing 
dosages higher than their respective IC50 at 24 h of treatment. 
However, at highest dosage, of all five antibiotics at 1280mg/L 
significant decrease in the cell viability was not observed.  
 
Results of conjugation experiment 
Successful transconjugation was noted with the A. baumannii 
isolate that harbored blaNDM-1 gene. The transfer of blaNDM-1 
gene to the E. coli XL-1 Blue was confirmed by both PCR and 
MIC testing. PCR targeting blaNDM-1 proved that the 
transconjugants carried the blaNDM-1 gene and MIC results 
showed similar antibiotic results when compared to the 
parental donor strains tested. Transconjugants grown in LB 
medium incorporated with antibiotics is shown in (Figure 4). 
 
 
Figure 4: Conjugation experiment showing the growth of 
transconjugants confirming the ability of transferring genetic 
material carrying drug resistance genes to competent  
 
Cells Molecular modelling  
As discussed earlier, the missing residues (167-170) (Figure 5A) 
of 3SOZ_A [36] was modeled using Swiss model beta server 
with advanced modeling option with 3SOZ_A as template. The 
modeled structure was refined, validated and was utilized for 
further docking studies. 
 
 
Figure 5: (A) Crystallized 3D structure of blaNDM-1 in E. coli. 
Magenta color circle show missing loop region in this structure;  
(B) 3D Structure of blaNDM-1. In this figure red color indicate 
helix, yellow color indicate beta strand, green color indicate coil, 
blue color indicate missing loop region of template structure BIOINFORMATION  open access 
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using USCF – CHIMERA; (C) C-alpha Backbone residue-wise 
root mean square deviation (RMSD) of blaNDM-1 at 5ns; (D) 
Potential energy graph over 5ns. The lowest potential energy 
was noted at 2000ps, marked with a Magenta circle. 
 
Structure validation 
The loop fixed model of blaNDM-1 was subjected to further 
structural validation through Q-mean server. This server 
predicted a structure score of 0.68. The PROCHECK analysis 
shows 92.1% residues in favored regions, 7.9% in allowed 
region and 0% in disallowed region. The final refined structure 
of  blaNDM-1 was used for further molecular dynamics 
simulation studies (Figure 5B). 
 
Molecular dynamics studies 
Molecular Dynamics simulation for 5 nanoseconds revealed the 
conformational changes and stability of the protein in response 
to optimal ensemble conditions as shown in (Figure 5c). The 
Potential energy traces a reliable drop in value over 5ns of MD 
simulation, with the lowest potential energy structure observed 
at 2000ps as shown in (Figure 5d). 
 
 
Figure 6: Active site pocket of blaNDM-1. Wire frame 
illustrated in overall protein and Green color ball illustrated in 
active site residues. 
 
Active site prediction 
Active site pocket idenitification was performed using CASTP 
Server, which predicted 26 different pockets with varied Area 
and Volume. Each pocket conformation presents residues that 
matched with the structure of blaNDM-1 in E. coli [PDB id: 
3SOZ_A]  [32]. Overall documented active site residues of 
blaNDM-1 were corresponding to the 26th pocket (Met21, Phe24, 
Val27, Ala28, Trp47, His74, His76, Asp78, Leu102, Glu106, 
His143, Thr146, Gly161, Cys162, Ile164, Lys165, Asp166, Lys168, 
Ala169, Lys170, Ser171, Leu172, Asp177, Tyr183, Met202, 
Ser203, His 204,  and Ser205) as shown in (Figure 6). 
 
Ligand optimization 
All the ligands were retrieved from Ligand Depot, Pubchem and 
Drug Bank based on availability. These ligands were 
minimization using for using GROMOS forcefield option of 
PRODRG Server and was further used of docking studies. 
 
Docking studies of blaNDM-1 
Docking studies of the chosen ligands were performed on the 
predicted active site region of blaNDM-1. The binding energy of 
all the interactions reveal that, among all the ligands, the 
highest binding affinity of (-6.17Kcal/mol) was observed for 
Cefoperazone. The detailed hydrogen bonding interactions and 
inhibitory constant value of blaNDM-1 with all the ligands are 
shown in (Figure 7), and Table 2 (see supplementary material) 
respectively. The docking studies show hydrophobic 
interactions, and hydrogen bonds, which very well correlated 
with the documented studies.  
 
 
Figure 7: Docking studies of blaNDM-1 protein with all the 
inhibitors. Green color sticks indicates ligand, Green color 
doted lines hydrogen bond. 
 
Ceftriaxone 
 Lys 165, Ser 203 and Asp 177 were found to form 3 hydrogen 
bonds with that of ceftriaxone (Figure 7A). These hydrogen 
bonds were found to stabilize the binding of ceftriaxone. The 
IC50 of the drug was found to be 144.25μM. 
 
Cefepime 
The result of cefepime docking into the reported active site of 
blaNDM-1 is shown in (Figure 7B). Under careful observation 
three hydrogen bonds were found to be formed with the 
following residues: Lys 165, Ser 203 and Ala 28. The IC50 of the 
drug was found to be 166.4μM. BIOINFORMATION  open access 
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Cefoperazone 
Cefoperazone was found to dock into the reported active site of 
blaNDM-1 is shown in (Figure 7C). A through examination of 
the binding pocket indicated that cefoperazone formed three 
hydrogen bonds with the residue of Ser 205, Lys 165 and His 
204. The IC50 of the drug was found to be 123.90μM. 
 
Imepenum 
Lys 165, Ser 203, Gly 161, Asp 78 and Ser 205 were found to 
f o r m  5  h y d r o g e n  b o n d s  w i t h  t h a t  o f  I m e p e n u m  i s  s h o w n  i n  
(Figure 7D). These hydrogen bonds were found to stabilize the 
binding of imepenum. The IC50 of the drug was found to be 
267.24μM.  
 
Meropenum 
The result of meropenum docking into the reported active site 
of blaNDM-1 is shown in (Figure 7E). Under careful observation 
s i x  h y d r o g e n  b o n d s  w e r e  f o u n d  t o  b e  f o r m e d  w i t h  t h e  
following residues: Lys 165, Ser 203, Gly 161, Asp 78, Ile 164 
and His 204. The IC50 of the drug was found to be 208.62μM. 
 
Discussion: 
Over the past decade, increased prevalence of multidrug-
resistant strains of A. baumannii (MDR-AB) has been reported. 
The prevalence of strains resistant to the usually potent and safe 
β-lactam antibiotics, such as ampicillin-sulbactam and 
carbapenems, had increased substantially [36-40]. Since the new 
antimicrobial agents for Gram-negative pathogens shrinks, the 
longevity of existing compounds becomes a matter of primary 
concern [41]. Many Acinetobacter are now resistant to commonly 
used antibacterial drugs, including penicillins, expanded-
spectrum cephalosporins [38, 42] cephamycins, 
aminoglycosides  [43] chloramphenicol, and tetracyclines [37]. 
Carbapenems have become the drugs of choice against 
Acinetobacter  infections in many centers but are slowly being 
compromised by the emergence of carbapenem-hydrolyzing ß-
lactamases [44]. Most potent emerging carbapenemase gene is 
New Delhi metallo-beta-lactamases (blaNDM-1). The first clue 
for the presence of a carbapenemase was inferred from the 
increased minimum inhibitory concentration (MIC) especially to 
imipenem, or meropenem. In our previous study, MIC results of 
A. baumannii isolate showed resistance to Ceftazidime, 
Ceftriaxone, Cefoperazone/Sulbactum, Cefepime, Imipenum 
and Meropenum (Data not shown for reference). In the current 
study, the MIC data and the docking results were in 
concordance and resistance could be attributed to the biofilm 
production. The reproducibility of obtained experimental 
results confirmed the predictive accuracy. Yong et al., 2009 
documented cephalosporins group of antibiotics as most 
potential inhibitors of blaNDM1, which was observed in our 
study in terms of Biofilm production and inhibitory mode of 
interactions. However, carbapenem group of antibiotics studied 
w e r e  p r o v e n  t o  b e  m o r e  s i g n i f i c a n t  w h e n  c o m p a r e d  t o  
cephalosporins. Liang Z, (2011) et al. [45] has reported blaNDM-
1 contains an additional insert between residues 162 and 166, 
which is not present in other MBLs. Since the insert is in the 
opposite side of the active site, with a distance of around 20 Å, 
its role in the hydrolysis reaction is still unknown. Interestingly, 
in our study we found both cephalosporins to interact with LYS 
165, whist, carbapenem group was found to interact with 
GLY161 and LYS165. However, this prediction needs to be 
confirmed by other structural biology methods.  
Conclusion: 
We have demonstrated the correlation between blaNDM–1 
positivity, and biofilm production with molecular interactions 
inferred through in silico docking studies which have attributed 
to high level resistance. Further by this study, we also highlight 
the importance of 162-166 region of blaNDM-1 as a potential site 
for drug targeting. 
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Supplementary material: 
 
Table 1: Classification of bacterial adherence by Tissue Culture Plate method 
Mean OD values  Adherence  Biofilm formation 
<0.120 Non    Non  /  weak 
0.120-0.240 Moderate  Moderat 
>0.240 Strong  High 
 
Table 2: Showing the docking results of docking interactions and IC50 calculation. 
Ligands Binding  Energy 
(Kcal/mol) 
No. of H-bonds  H- BONDS  Ic 50 of BiofilmMTT 
Assay  (mg/L) 
Experimental 
IC50 (μM) 
Ceftriaxone  -5.68  3  LYS 165, SER 203, ASP 177  80  144.25 
Cefepime  -5.48  3  LYS 165, SER 203, ALA 28  80  166.47 
Cefoperazone  -6.17  3  SER 205, LYS 165, HIS 204   80  123.90 
Imipenem  -5.61  5  LYS 165, SER 203, GLY 161, 
ASP 78, SER 205 
80 267.24 
Meropenem  -4.74  6  LYS 165, SER 203, GLY 161, 
ASP 78, ILE 164, HIS 204 
80 208.62 
 
 
 
 
 
 
 
 
 
 
 
 